IP Library Granted Patent US 11,014,129
Granted Patent B2
US 11,014,129 · App. 14/912,440 · Granted May 25, 2021

Methods of cleaning a protein A based affinity chromatography column

Inventors: Nanying Bian (Lexington, MA); Sapna Mehtani (Somerville, MA); John Dana Hubbard (Billerica, MA)
Assignee: EMD Millipore Corporation
B08B9/027A61L2/18B08B3/08C07K1/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,014,129
App. No.
14/912,440
Granted
May 25, 2021
Kind
B2
Abstract

The present invention provides methods for cleaning a Protein A chromatography column employing a media comprising a Protein A ligand derived from the C domain of Staphylococcus aureus , such that the column can be cleaned using both acidic and alkaline solutions.

Claims (20)

1. A method of preserving the dynamic binding capacity of an affinity chromatography column over one or more affinity purification cycles, the method comprising: cleaning steps consisting essentially of cleaning the chromatography column after one or more affinity purification cycles with an acidic solution consisting essentially of phosphoric acid and having a pH lower than 3.0 wherein the affinity chromatography column comprises a Protein A media comprising a Protein A ligand derived from the C domain of Staphylococcus aureus Protein A immobilized onto a solid support comprising a polymer selected from the group consisting of polyvinylether, polyvinylalcohol, polymethacrylate, polyacrylate, polystyrene, polyacrylamide, polymethacrylamide and polycarbonate, wherein the dynamic binding capacity is preserved for 50-200 cycles.

2. The method of claim 1 , wherein the Protein A ligand comprises an amino acid sequence selected from SEQ ID NO: 3 and SEQ ID NO: 4.

3. The method of claim 1 , wherein the acidic solution comprises a pH of 2.5.

4. The method of claim 1 , wherein the acidic solution comprises a pH of 2.0.

5. The method of claim 1 , wherein the acidic solution comprises a pH of 1.5.

6. The method of claim 1 , wherein the dynamic binding capacity is preserved for 50-100 cycles.

7. The method of claim 1 , wherein the dynamic binding capacity is preserved 100-200 cycles.

8. The method of claim 1 , wherein the solid support comprises a polyvinylether polymer.

9. A method of cleaning an affinity chromatography column using both acidic and alkaline solutions, the method comprising: cleaning steps consisting essentially of a) contacting the column with both acidic and alkaline solutions, wherein the acidic solution consists essentially of an acid and the alkaline solution consists essentially of an alkali, between affinity purification cycles; or b) contacting the column with either an acidic solution after a cycle or an alkaline solution after a cycle, wherein the acidic solution consists essentially of an acid and the alkaline solution consists essentially of an alkali, such that the acidic and alkaline solutions are used in an alternating manner, wherein the affinity chromatography column comprises a Protein A media comprising a Protein A ligand derived from the C domain of Staphylococcus aureus Protein A immobilized onto a solid support, wherein the dynamic binding capacity is preserved for 50-200 cycles.

10. The method of claim 9 , wherein the solid support comprises a polymer selected from the group consisting of polyvinylether, polyvinylalcohol, polymethacrylate, polyacrylate, polystyrene, polyacrylamide, polymethacrylamide and polycarbonate.

11. The method of claim 9 , wherein the acidic solution consists essentially of phosphoric acid.

12. The method of claim 9 , wherein the alkaline solution consists essentially of sodium hydroxide.

13. The method of claim 9 , wherein the method results in a synergistic removal of impurities.

14. The method of claim 9 , wherein the ligand comprises an amino acid sequence selected from SEQ ID NO:3 or SEQ ID NO:4.

15. The method of claim 1 , wherein the alkaline solution is from 0.1 M sodium hydroxide to 0.5 M sodium hydroxide.

16. The method of claim 9 , wherein the sodium hydroxide solution is from 0.1 M sodium hydroxide to 0.5 M sodium hydroxide.

17. The method of claim 9 , wherein the dynamic binding capacity is preserved 50-100 cycles.

18. The meth od of claim 9 , wherein the dynamic binding capacity is preserved 100-200 cycles.

19. The method of claim 1 , wherein there is no significant change in dynamic binding capacity for 50-200 cycles.

20. The method of claim 9 , wherein there is no significant change in dynamic binding capacity for 50-200 cycles.

Assignments (2)
CHANGE OF ADDRESS Recorded Feb 15, 2018
From: EMD MILLIPORE CORPORATION
To: EMD MILLIPORE CORPORATION
Reel/Frame 045341/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2016
From: BIAN, NANYING; MEHTANI, SAPNA; HUBBARD, JOHN DANA
To: EMD MILLIPORE CORPORATION
Reel/Frame 038215/0148 →